Terremoto Biosciences Inc. has synthesized new 3H-imidazo[4,5-b]pyridine compounds acting as RAC-α serine/threonine-protein kinase (AKT1; PKB-α) inhibitors reported to be useful for the treatment of ...
This is achieved by the interaction between the potassium ion channel AKT1 and the potassium transporter HAK5. "Although HAK5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback